SHPHF 財務： Sihuan Pharmaceutical Holdings Group Ltd AI 分析

首頁

股票

SHPHF

財務狀況

SHPHF 財務

Sihuan Pharmaceutical Holdings Group Ltd

$0.18

收盤價：Mar 24, 16:00:00 GMT-4

$0.18

盤後：Mar 24, 20:00:00 GMT-4

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

SHPHF 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	2,097	1,901	1,860	2,181	3,038	2,464
營收年增率 (YoY)	20%	2%	-15%	-28%	23%	-14%
營收成本	707	659	564	693	607	549
毛利	1,390	1,241	1,295	1,487	2,430	1,914
銷售、一般及管理費用	1,165	1,175	911	1,023	1,128	858
研發	431	473	577	936	868	729
營業費用	1,544	1,631	1,436	2,023	1,754	1,428
其他非營業收入 (費用)	--	--	--	--	--	--
稅前淨利	-252	-428	-161	-2,122	496	765
所得稅費用	85	43	96	196	253	219
淨利	-80	-216	-54	-1,914	416	473
淨利成長	115.99%	300%	-97%	-560%	-12%	-117%
稀釋後流通股數	9,204.01	9,265.98	9,297.07	9,329.99	9,483.38	9,465.68
股數年變動 (YoY)	-1%	0%	0%	-2%	0%	0%
每股盈餘 (稀釋)	0	-0.02	0	-0.2	0.04	0.05
每股盈餘成長率	112%	303%	-97%	-565%	-16%	-119%
自由現金流	-71	57	-95	-547	-60	-353
每股自由現金流	--	--	--	--	--	--
毛利率	66.28%	65.28%	69.62%	68.17%	79.98%	77.67%
營業利益率	-7.34%	-20.46%	-7.52%	-24.57%	22.25%	19.68%
淨利率	-3.81%	-11.36%	-2.9%	-87.75%	13.69%	19.19%
自由現金流利潤率	-3.38%	2.99%	-5.1%	-25.08%	-1.97%	-14.32%
EBITDA	78	-143	76	-175	977	755
EBITDA 利潤率	3.71%	-7.52%	4.08%	-8.02%	32.15%	30.64%
EBITDA 中的折舊與攤銷	232	246	216	361	301	270
EBIT	-154	-389	-140	-536	676	485
EBIT 利潤率	-7.34%	-20.46%	-7.52%	-24.57%	22.25%	19.68%
有效稅率	-33.73%	-10.04%	-59.62%	-9.23%	51%	28.62%

Follow-Up Questions

Sihuan Pharmaceutical Holdings Group Ltd 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Sihuan Pharmaceutical Holdings Group Ltd 的總資產為 $10,531，淨損失為 $-216

SHPHF 的關鍵財務比率是什麼？



Sihuan Pharmaceutical Holdings Group Ltd 的流動比率為 1.7，淨利潤率為 -11.36，每股銷售為 $0.2。

Sihuan Pharmaceutical Holdings Group Ltd 的收入按細分市場或地理位置如何劃分？



Sihuan Pharmaceutical Holdings Group Ltd 最大收入來源為 Generic Medicine，在最近的收益報告中收入為 1,191,874,310。就地區而言，China 是 Sihuan Pharmaceutical Holdings Group Ltd 的主要市場，收入為 2,047,607,773。

Sihuan Pharmaceutical Holdings Group Ltd 是否盈利？



無，根據最新的財務報表，Sihuan Pharmaceutical Holdings Group Ltd 的淨損失為 $-216

Sihuan Pharmaceutical Holdings Group Ltd 有負債嗎？



是的，Sihuan Pharmaceutical Holdings Group Ltd 的負債為 6,159

Sihuan Pharmaceutical Holdings Group Ltd 的流通股有多少？



Sihuan Pharmaceutical Holdings Group Ltd 的總流通股為 9,244.06

關鍵數據

前收市價

$0.1865

開盤價

$0.1865

當日範圍

$0.1865 - $0.1865

52週區間

$0.0492 - $0.235

交易量

300

平均成交量

1.6K

股息收益率

每股盈餘 (TTM)

0.00

市值

$1.7B

什麼是 Sihuan Pharmaceutical Holdings ？

Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 2,767 full-time employees. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.

功能特性

資源